Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition

Por Audeh, M William
Publicado em 2014

Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology

Por Xie, Yu, Collins, William J., Audeh, M. William, Shiao, Stephen L., Gottlieb, Roberta A., Goodman, Marc T., Bairey Merz, C. Noel, Mehta, Puja K.
Publicado no Curr Treat Options Cardiovasc Med (2015)

A breast cancer gene signature for indolent disease

Por Delahaye, Leonie J. M. J., Drukker, Caroline A., Dreezen, Christa, Witteveen, Anke, Chan, Bob, Snel, Mireille, Beumer, Inès J., Bernards, Rene, Audeh, M. William, van’t Veer, Laura J., Glas, Annuska M.
Publicado no Breast Cancer Res Treat (2017)

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

Por Kaufman, Bella, Shapira-Frommer, Ronnie, Schmutzler, Rita K., Audeh, M. William, Friedlander, Michael, Balmaña, Judith, Mitchell, Gillian, Fried, Georgeta, Stemmer, Salomon M., Hubert, Ayala, Rosengarten, Ora, Steiner, Mariana, Loman, Niklas, Bowen, Karin, Fielding, Anitra, Domchek, Susan M.
Publicado no J Clin Oncol (2015)

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

Por Domchek, Susan M, Aghajanian, Carol, Shapira-Frommer, Ronnie, Schmutzler, Rita K, Audeh, M William, Friedlander, Michael, Balmaña, Judith, Mitchell, Gillian, Fried, Georgeta, Stemmer, Salomon M, Hubert, Ayala, Rosengarten, Ora, Loman, Niklas, Robertson, Jane D, Mann, Helen, Kaufman, Bella
Publicado no Gynecol Oncol (2015)